These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 2458082

  • 1. Clinical evidence of secretory IgA and Schwangerschaftsprotein 1 in pleural effusions of lung cancer patients.
    Briese V, Brock J, Willroth PO, Szabo DG, Than GN, Richter D.
    Arch Geschwulstforsch; 1988; 58(3):169-74. PubMed ID: 2458082
    [Abstract] [Full Text] [Related]

  • 2. [Tumor markers (alpha 2-macroglobulin, secretory immunoglobulin A, pregnancy-associated alpha 2-glycoprotein) in the serum of patients with bronchial carcinoma].
    Briese V, Willroth PO, Brock J, Straube W.
    Arch Geschwulstforsch; 1984; 54(5):391-8. PubMed ID: 6208875
    [Abstract] [Full Text] [Related]

  • 3. [Levels of tumor markers (orosomucoid, pregnancy-associated alpha 2-glycoprotein, pregnancy protein-1, placental specific-tissue protein 10, placental specific-tissue protein 12, alpha 1-fetoprotein) in the serum of patients with bronchial carcinoma].
    Briese V, Szabo DG, Than GN, Willroth PO, Straube W.
    Arch Geschwulstforsch; 1986; 56(1):13-22. PubMed ID: 2421681
    [Abstract] [Full Text] [Related]

  • 4. [Oligomeric and monomeric IgA and secretory piece in pleural effusions].
    Scrobogna S, Trani S.
    Quad Sclavo Diagn; 1977 Dec; 13(4):449-57. PubMed ID: 614605
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical usefulness of tumor markers in the diagnosis of pleural effusions. Carcinoembryonic antigen, alpha-fetoprotein and orosomucoid].
    Romero Candeira S, Hernández Blasco L, Senent Español C, García Raja A, Zaragoza Zaragoza C, Serralta Buades J, Martín Serrano C.
    Med Clin (Barc); 1986 Mar 22; 86(11):439-43. PubMed ID: 2423819
    [No Abstract] [Full Text] [Related]

  • 7. Orosomucoid content of pleural and peritoneal effusions.
    Rudman D, Chawla RK, Del Rio AE, Hollins BM, Hall EC, Conn JM.
    J Clin Invest; 1974 Jul 22; 54(1):147-55. PubMed ID: 4209434
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Behavior of some tumor markers (secretory immunoglobulin A, pregnancy-associated alpha 2-glycoprotein, circulating immune complexes in the serum of patients with breast tumors].
    Briese V, Strache RR, Büttner HH, Kunze M, Brock J, Röpcke G.
    Zentralbl Gynakol; 1987 Jul 22; 109(5):265-73. PubMed ID: 3591061
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential diagnosis of pleural effusions: clinical usefulness of cell marker quantitation.
    Vladutiu AO, Brason FW, Adler RH.
    Chest; 1981 Mar 22; 79(3):297-301. PubMed ID: 6162619
    [Abstract] [Full Text] [Related]

  • 12. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
    Ni SS, Gao ZL.
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb 22; 16(2):81-2, 123. PubMed ID: 8221956
    [Abstract] [Full Text] [Related]

  • 13. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H, Rona G, Hutter C, Bayer PM, Kummer F.
    Wien Klin Wochenschr; 1986 Sep 12; 98(17):564-73. PubMed ID: 3020811
    [Abstract] [Full Text] [Related]

  • 14. Preliminary results concerning the presence of secretory immunoglobulin A (SIgA) in the serum of patients with IgA myeloma.
    Buzilă L, Schell HD, Funduc I, Ostafe V, Szedlacsek SE.
    Arch Roum Pathol Exp Microbiol; 1989 Sep 12; 48(2):163-70. PubMed ID: 2517469
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
    Hamed EA, El-Noweihi AM, Mohamed AZ, Mahmoud A.
    Respirology; 2004 Mar 12; 9(1):81-6. PubMed ID: 14982607
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.